By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
MedsparkMedsparkMedspark
  • Home
  • News & Alerts
    News & AlertsShow More
    Medicare’s AI approval pilot drew warnings before it launched
    By
    msadmin
    September 16, 2026
    GE HealthCare’s new AI tools forecast hospital bottlenecks 72 hours out
    By
    msadmin
    September 16, 2026
    Knowtex bets on evaluation science to sell clinical AI to hospitals
    By
    msadmin
    September 16, 2026
    Pediatric heart models now take seconds instead of a workday
    By
    msadmin
    September 16, 2026
    OpenAI Foundation puts $40M behind cancer vaccine data collection
    By
    msadmin
    September 16, 2026
  • Spotlight
    SpotlightShow More
    Robinhood Ventures Fund II brings retail capital to healthcare AI
    By
    msadmin
    August 13, 2026
    Adialante brings accessible MRI-based cancer screening
    By
    msadmin
    August 11, 2026
    CellType models biology so AI can discover drugs
    By
    msadmin
    August 11, 2026
    Healthcare AI startups in Robinhood Ventures Fund II
    By
    msadmin
    August 11, 2026
    OpenAI launches GPT-Rosalind for life sciences research
    By
    msadmin
    July 17, 2026
  • Articles
    ArticlesShow More
    Proteomics model picks breast cancer drugs from biopsies
    By
    msadmin
    September 10, 2026
    CRISP model reads frozen sections to steer cancer surgery
    By
    msadmin
    September 10, 2026
    Consumer chatbots are building a medical system outside hospitals
    By
    msadmin
    August 21, 2026
    Reasoning gaps hold back AI agents in scientific discovery
    By
    msadmin
    August 11, 2026
    Benchmark scores can’t track real clinical LLM use, Stanford says
    By
    msadmin
    August 11, 2026
  • About
    • Mission
    • Services
    • Contact
  • Shop
    • All Items
    • By Category
    • Cart
  • Newsletter
Font ResizerAa
MedsparkMedspark
Font ResizerAa
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • About
  • Shop
  • Newsletter
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • About
    • Mission
    • Services
    • Contact
  • Shop
    • All Items
    • By Category
    • Cart
  • Newsletter
Follow US
News & Alerts

PointCaré Raises €1.5M to Bring Real-Time AI Decision Support to Critical Care

The Ghent-based medtech startup is revolutionizing intensive care with its OnTarget platform, using agentic AI to deliver real-time, context-aware clinical guidance.

Yu Chi Huang
By
Yu Chi Huang
Yu Chi Huang
ByYu Chi Huang
Yu Chi is a senior regulatory affairs specialist and medical researcher focusing on medical devices.
Published: June 19, 2025
Share
3 Min Read
SHARE

As first reported by Tech.eu, Ghent-based medtech startup PointCaré has raised nearly €1.5 million in funding from private investors to further develop and clinically validate its flagship platform, OnTarget. The AI-powered system is designed to centralize and interpret the overwhelming amount of data generated in operating rooms (ORs) and intensive care units (ICUs), providing clinicians with clear, context-based recommendations in real time.

Contents
A founder with a uniquely interdisciplinary visionTackling alarm fatigue and inefficiencies head-onPositioning for international growth and regulatory approval

Source: pointcare.be.

A founder with a uniquely interdisciplinary vision

PointCaré was founded in 2022 by Dr. Henri Van Overmeire, a polymath whose background spans astrophysics, medicine, anesthesiology, and civil engineering. His experience on the front lines of critical care made it clear that despite high-tech equipment, many hospitals lack integrated systems that transform raw data into actionable insights. This gap inspired the development of OnTarget, which leverages proprietary agentic AI to deliver personalized clinical support — while avoiding the “black box” pitfalls of traditional AI models.

Tackling alarm fatigue and inefficiencies head-on

Modern ICUs and ORs are saturated with disconnected devices that generate immense data streams but fail to provide meaningful guidance. Dr. Van Overmeire emphasizes that these tools often ignore individual patient context, contributing to suboptimal treatments and alarm fatigue among staff. OnTarget addresses this challenge by unifying data sources, analyzing them in real time with full situational awareness, and presenting transparent, traceable recommendations to caregivers — enhancing patient outcomes while easing clinician burden.

Positioning for international growth and regulatory approval

Led by CEO Veronique Pattyn, PointCaré is not only developing a next-generation AI solution but also laying the groundwork for long-term scalability. The company has already filed its first patent and is preparing for European MDR approval. With commercialization targeted for 2028, the startup aims to set a new global standard for clinical decision support systems in high-acuity settings.

PointCaré’s OnTarget platform is a bold step toward redefining how healthcare teams interact with data in life-critical environments. By merging AI transparency with clinical relevance, the company is addressing longstanding inefficiencies in critical care — with the goal of improving both patient outcomes and provider workflows worldwide.

VIA:Tech.eu
Share This Article
Facebook Copy Link Print
Yu Chi Huang
ByYu Chi Huang
Yu Chi is a senior regulatory affairs specialist and medical researcher focusing on medical devices.

You Might Also Like

News & Alerts

Hospital-built AI screens myeloma trial candidates in seconds

By
msadmin
September 3, 2026
News & Alerts

FDA and CMS court AI health startups in closed-door demo day

By
msadmin
August 6, 2026
News & Alerts

GE HealthCare’s new AI tools forecast hospital bottlenecks 72 hours out

By
msadmin
September 16, 2026
News & Alerts

Mayo Clinic AI finds drug path to ‘undruggable’ cancer protein

By
msadmin
August 12, 2026

AI news, analysis, and insights for healthcare, biotech, and pharma.

Facebook Twitter Youtube Linkedin
Quick Links
  • News & Alerts
  • Articles
  • Spotlight
  • Events
About Medspark
  • Mission
  • Services
  • Contact

© Copyright 2026 MedSpark. All rights reserved.

Privacy Policy | Legal